LINDEN ADVISORS LP Ibere Pharmaceuticals Transaction History

LINDEN ADVISORS LP portfolio value:

$4.45M
portfolio value

LINDEN ADVISORS LP quarter portfolio value change:

+1.02%
quarter

Ibere Pharmaceuticals 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 45K $9.91 450K
Q2 2022 share 0.00% 0 shares 0 $9.81 450K
Q1 2022 share 0.00% 0 shares 49K $9.81 450K
Q4 2021 share 0.00% 0 shares 4K $9.72 450K
Q3 2021 share 0.00% 0 shares 10K $9.69 450K
Q2 2021 share Increase 0.00% 450K shares 4.35M $9.67 450K